Client PortalSchedule a Call
Client PortalSchedule a Call
Illustration

Amanda Cooper,M&A Advisor

Partnering for Strategic Medtech Exits That Matter

From developing engagement strategies for innovative medical device developers to structuring meaningful acquisitions, I’ve spent over fifteen years at the intersection of medtech innovation, business strategy and M&A. I understand the technical challenges of medical device development, the motivations of founders and physician-inventors, and the financial imperatives of investors seeking value and liquidity.
My Story
My journey began in technology and executive communications, but early exposure to the medtech world altered my trajectory. As I worked alongside physician-inventors, engineers and startup teams, I saw how groundbreaking innovations too often stalled — not for lack of quality, but for lack of strategic alignment and exit preparedness. 
I founded AE Cooper Medical Ventures to serve a niche I felt was underserved: early-stage and pre-commercial medtech companies (and the funds backing them) pursuing exits under ~$25 M. These are deals where standard “big-house” bankers don’t focus, but where smart partnerships and thoughtful planning can yield meaningful outcomes.

What Sets Us Apart

    Medtech-Specific Expertise: Unlike generalist advisors, I’ve lived and breathed medical-device development — including clinical, regulatory, manufacturing and commercialization stages. That allows me to translate technical potential into strategic buyer appeal.

    Founder & Investor Aligned: I believe exits should reward founders, reassure investors, and serve patients. Every engagement is built to align interests, protect relationships and deliver value beyond the deal.

    Discreet, Partnership-Driven Approach: No hype. No one-size-fits-all. My practice runs with confidentiality, respect and a focus on durable outcomes — not quick flips.

    Focused Deal Range: I specialize in the often-overlooked “small-ball” medtech exit range (under ~$25 M) where process discipline and niche buyer insight matter most.

Services

How We Engage

Whether you are a founder, physician-inventor or board member seeking clarity on your exit path — or an investor managing a portfolio of medtech assets under pressure — we tailor our work to your situation. From self-guided toolkits to full deal leadership, each engagement is structured to match your needs, timeline and objectives.

Our Promise

At the heart of this work is a simple promise: to bring all our expertise and effort to bear to help medtech innovators and investors create exits that matter — for companies, for funds and for patients.If you’re ready to explore how an aligned, strategic exit could be your next chapter, let’s talk.